Dementia Discovery Fund — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
LoQus23loqus23.cominNov 2021
LoQus23 Therapeutics is a drug discovery company developing treatments for triplet repeat expansion diseases such as Huntington's disease, focused on preclinical CNS and neuroscience research.
BiotechDeep TechCambridge, GB
David Reynolds(Co-founder & CEO)inCaroline Benn(Co-founder & CSO)in
Co-investorsNovartis Venture FundSV Health InvestorsForbion
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.